Case Report: Treatment of an unresectable mucoepidermoid carcinoma with osimertinib - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Case Study: Osimertinib as a Therapeutic Approach for Unresectable Mucoepidermoid Carcinoma

  • By

  • Leonardo Villa

  • Alice Soares

  • Viviane Basílio

  • Haonne Abboud

  • Daniel Herchenhorn

  • September 11, 2026

Share

Original Source(s)

Case Report: Treatment of an unresectable mucoepidermoid carcinoma with osimertinib

  • by Leonardo Villa, Alice Soares, Viviane Basílio, Haonne Abboud, Daniel Herchenhorn

  • September 11, 2026

Related Content

Retraction Note: Lycorine inhibits angiogenesis by docking to PDGFRα

Cost-Effectiveness of Electronic Patient-Reported Outcome Measure Interventions in Cancer: Systematic Review and Parameter Extraction for Economic Modeling

Retraction Note: TWIST1 activates cancer stem cell marker genes to promote epithelial‑mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma